Neurodegeneration in Diabetic Retinopathy： Current Concepts and Therapeutic Implications  

作　　者：Ning-Li Wang 

机构地区：[1]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing 100005, China

出　　处：《Chinese Medical Journal》2016年第24期3001-3003,共3页中华医学杂志（英文版）

摘　　要：The prevalence of diabetes mellitus （DM） has increased significantly in recent decades in China. Recently, it has been reported that the estimated prevalence of DM among a representative sample of Chinese adults was 11.6% and the prevalence of prediabetes was 50.1%. Furthermore, the awareness, treatment, and control rates of DM in the general Chinese population are disproportionately low, raising concerns for future high rates of diabetes-related morbidity and mortality.The prevalence of diabetes mellitus （DM） has increased significantly in recent decades in China. Recently, it has been reported that the estimated prevalence of DM among a representative sample of Chinese adults was 11.6% and the prevalence of prediabetes was 50.1%. Furthermore, the awareness, treatment, and control rates of DM in the general Chinese population are disproportionately low, raising concerns for future high rates of diabetes-related morbidity and mortality.

关 键 词：Diabetic Retinopathy NEURODEGENERATION NEUROPROTECTION 

分 类 号：R587.2[医药卫生—内分泌] R774.1[医药卫生—内科学]